The Patent Finder

Delenex Therapeutics AG

Also on record
Records under this name other than patents Delenex Therapeutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Delenex Therapeutics AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,404,930Antibody to Human IL-1 Beta
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,077,302Method of Inhibiting Human IL-1 Beta by Administering an Antibody to Human IL-1 Beta
Formerly held
Lapsed on the fee record
Ended Sep 18, 2026 · High confidence
Lapsed on the fee recordEnded Sep 18, 2026High confidence
US 11,407,824Nucleic Acids Encoding Antibodies Against IL-1 Beta
Formerly held
Lapsed on the fee record
Ended Aug 9, 2026 · High confidence
Lapsed on the fee recordEnded Aug 9, 2026High confidence
US 9,914,772Antibodies Against IL-1 Beta
Formerly held
Lapsed on the fee record
Ended Mar 13, 2026 · High confidence
Lapsed on the fee recordEnded Mar 13, 2026High confidence
US 7,902,340Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
Formerly held
Lapsed on the fee record
Ended Mar 8, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 8, 2023USPTO record
US 8,945,563Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
Formerly held
Lapsed on the fee record
Ended Feb 3, 2023 · USPTO record
Lapsed on the fee recordEnded Feb 3, 2023USPTO record
US 9,512,411Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
Formerly held
Lapsed on the fee record
Ended Dec 6, 2020 · USPTO record
Lapsed on the fee recordEnded Dec 6, 2020USPTO record
US 9,273,126Humanized antibodies against the beta-amyloid peptide
Formerly held
Lapsed on the fee record
Ended Mar 1, 2020 · USPTO record
Lapsed on the fee recordEnded Mar 1, 2020USPTO record
US 8,323,647Humanized antibodies against the β-amyloid peptide
Formerly held
Lapsed on the fee record
Ended Dec 4, 2016 · USPTO record
Lapsed on the fee recordEnded Dec 4, 2016USPTO record
US 6,821,728Screening System
Formerly held
Lapsed on the fee record
Ended Nov 23, 2016 · High confidence
Lapsed on the fee recordEnded Nov 23, 2016High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited